学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

幕内梨恵（マクウチリエ）

研究テーマ	胃癌の手術治療
研究業績（論文）	1. Makuuchi R,Nunobe S,Ishizuka N,Atsumi S,Shoji Y,Ri M,Hayami M,Irino T,Ohashi M,Sano T. Prospective feasibility study of laparoscopic and robotic distal gastrectomy for advanced gastric cancer to verify the safety of surgical proximal margins. Ann. Gastroenterol. Surg.. 2025; (ags3.70141): . DOI: 10.1002/ags3.70141. 2. Makuuchi R,Terashima M,Terada M,Mizusawa J,Kita R,Tokunaga M,Omori T,Ojima T,Ehara K,Watanabe M,Yanagimoto Y,Nunobe S,Kinoshita T,Ito S,Nishida Y,Hihara J,Boku N,Kurokawa Y,Yoshikawa T,Stomach Cancer Study Group of Japan Clinical Oncology Group. Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol. BMC Cancer. 2023; 23(1): 987. DOI: 10.1186/s12885-023-11481-2. 3. Makuuchi R,Kamiya S,Tanizawa Y,Bando E,Terashima M. Robotic surgery for gastric cancer. Mini-invasive Surg.. 2019; 2019: . DOI: 10.20517/2574-1225.2019.03. 4. Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Esophagojejunal anastomotic leakage following gastrectomy for gastric cancer. Surg. Today. 2019; 49(3): 187-196. DOI: 10.1007/s00595-018-1726-8. 5. Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Pancreaticoduodenectomy for gastric cancer. J. Cancer Metastasis Treat.. 2018; 4(6): 26. DOI: 10.20517/2394-4722.2018.15. 6. Makuuchi R,Sugisawa N,Kaji S,Hikage M,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Terashima M. Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading. Eur. J. Surg. Oncol.. 2017; 43(1): 210-217. DOI: 10.1016/j.ejso.2016.07.140. 7. Makuuchi R,Terashima M,Kusuhara M,Nakajima T,Serizawa M,Hatakeyama K,Ohshima K,Urakami K,Yamaguchi K. Comprehensive analysis of gene mutation and expression profiles in neuroendocrine carcinomas of the stomach. Biomed. Res.. 2017; 38(1): 19-27. DOI: 10.2220/biomedres.38.19. 8. Honda M,Makuuchi R,Nunobe S,Yamabuki T,Ogawa K,Akashi Y,Bamba T,Aizawa M,Waragai M,Hori S,Yamagata Y,Yoshikawa T. Surgical manipulation related to the risk of postoperative complications in laparoscopic gastrectomy: a case-control study assessing full surgical videos. Surg. Endosc.. 2025; 39(4): 2406-2414. DOI: 10.1007/s00464-025-11605-8. 9. Kaji S,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Omori H,Fujiya K,Nishiwaki N,Furukawa K,Nakamura K,Koseki Y,Waki Y,Asaoka R,Terashima M. Preventive effect on delayed gastric emptying of preserving the infra-pyloric vein in laparoscopic pylorus-preserving gastrectomy for early gastric cancer. Surg. Endosc.. 2020; 34(9): 3853-3860. DOI: 10.1007/s00464-019-07151-9. 10. Toriumi T,Makuuchi R,Kamiya S,Tanizawa Y,Bando E,Terashima M. Obesity is a risk factor for internal hernia after laparoscopic or robot-assisted gastrectomy with mesenteric defect closure for gastric cancer. Surg. Endosc.. 2020; 34(1): 436-442. DOI: 10.1007/s00464-019-06787-x. 11. Bando E,Makuuchi R,Irino T,Tanizawa Y,Kawamura T,Terashima M. Validation of the prognostic impact of the new tumor-node-metastasis clinical staging in patients with gastric cancer. Gastric Cancer. 2019; 22(1): 123-129. DOI: 10.1007/s10120-018-0799-9. 12. Waki Y,Makuuchi R,Nagata M,Furukawa K,Fujiya K,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. The current status and future perspective about robotic surgery for gastric cancer. Gan To Kagaku Ryoho. 2018; 45(12): 1690-1695. 13. Kawamura T,Makuuchi R,Tokunaga M,Tanizawa Y,Bando E,Yasui H,Aoyama T,Inano T,Terashima M. Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann. Surg. Oncol.. 2018; 25(6): 1625-1632. DOI: 10.1245/s10434-018-6452-3. 14. Miki Y,Makuuchi R,Honda S,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Yurikusa T,Tanuma A,Terashima M. Prospective phase II study evaluating the efficacy of swallow ability screening tests and pneumonia prevention using a team approach for elderly patients with gastric cancer. Gastric Cancer. 2018; 21(2): 353-359. DOI: 10.1007/s10120-017-0736-3. 15. Bando E,Makuuchi R,Tokunaga M,Tanizawa Y,Kawamura T,Terashima M. Impact of clinical tumor-node-metastasis staging on survival in gastric carcinoma patients receiving surgery. Gastric Cancer. 2017; 20(3): 448-456. DOI: 10.1007/s10120-016-0637-x. 16. Tokunaga M,Makuuchi R,Miki Y,Tanizawa Y,Bando E,Kawamura T,Terashima M. Late phase II study of robot-assisted gastrectomy with nodal dissection for clinical stage I gastric cancer. Surg. Endosc.. 2016; 30(8): 3362-3367. DOI: 10.1007/s00464-015-4613-z. 17. Miki Y,Makuuchi R,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Terashima M. Risk factors for postoperative pneumonia after gastrectomy for gastric cancer. Surg. Today. 2016; 46(5): 552-556. DOI: 10.1007/s00595-015-1201-8. 18. Tokunaga M,Makuuchi R,Miki Y,Tanizawa Y,Bando E,Kawamura T,Terashima M. Surgical and survival outcome following truly palliative gastrectomy in patients with incurable gastric cancer. World J. Surg.. 2016; 40(5): 1172-1177. DOI: 10.1007/s00268-015-3398-5. 19. Oba A,Shimane G,Makuuchi R,Kiritani S,Kobayashi K,Ri M,Ono Y,Hayami M,Irino T,Ito H,Inoue Y,Ohashi M,Nunobe S,Takahashi Y. ASO visual abstract: Robotic pancreatectomy as an adjunct to radical gastrectomy for advanced gastric cancer: Surgical and clinical implications. Ann. Surg. Oncol.. 2026; : . DOI: 10.1245/s10434-026-19168-1. 20. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Low preoperative prealbumin increases non-gastric cancer mortality in patients with early or advanced gastric cancer after gastrectomy: a retrospective cohort study. Surg. Today. 2026; 56(2): 152-164. DOI: 10.1007/s00595-025-03112-z. 21. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Preoperative prealbumin levels are prognostic predictors of overall survival, independent of inflammation severity, in patients with gastric cancer following gastrectomy. Surg. Today. 2026; : 46037. DOI: 10.1007/s00595-025-03164-1. 22. Kumagai K,Yoshida M,Ishida H,Ishizuka N,Ohashi M,Makuuchi R,Hayami M,Ida S,Ikenoyama Y,Namikawa K,Tokai Y,Yoshimizu S,Horiuchi Y,Ishiyama A,Yoshio T,Hirasawa T,Fujisaki J,Nunobe S. Utility and safety of near-infrared fluorescent marking clips for tumor localization in robot-assisted laparoscopic gastric cancer surgery. J. Gastrointest. Surg.. 2026; 30(1): 102280. DOI: 10.1016/j.gassur.2025.102280. 23. Sugita Y,Ohashi M,Miyazaki N,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Optimal cutoff size of large Borrmann type III gastric cancer: Is 8 cm accurate in predicting survival and incidence of peritoneal metastasis?. Ann. Gastroenterol. Surg.. 2026; 10(1): 77-86. DOI: 10.1002/ags3.70071. 24. Hayami M,Hu Q,Ri M,Makuuchi R,Irino T,Sano T,Nunobe S. Non-flap tunnel technique (NFTT): A novel minimally invasive reconstruction method after proximal gastrectomy for gastric and esophagogastric junction cancer. Ann. Gastroenterol. Surg.. 2026; 10(1): 87-94. DOI: 10.1002/ags3.70072. 25. Oba A,Shimane G,Makuuchi R,Kiritani S,Kobayashi K,Ri M,Ono Y,Hayami M,Irino T,Ito H,Inoue Y,Ohashi M,Nunobe S,Takahashi Y. Robotic pancreatectomy as an adjunct to radical gastrectomy for advanced gastric cancer: Surgical and clinical implications. Ann. Surg. Oncol.. 2025; : . DOI: 10.1245/s10434-025-18708-5. 26. Matsui R,Ohashi M,Ri M,Makuuchi R,Hayami M,Irino T,Sano T,Nunobe S. Postoperative impact of anti‐inflammatory drug on cancer recurrence in patients with locally advanced gastric cancer after curative gastrectomy: A pilot retrospective study. Ann. Gastroenterol. Surg.. 2025; (ags3.70110): . DOI: 10.1002/ags3.70110. 27. Morito A,Eto K,Tsubakihara H,Ida S,Makuuchi R,Miyazaki N,Irino T,Hayami M,Nunobe S,Iwatsuki M. Impact of gastrectomy for gastric cancer on postoperative bone mineral density loss and fracture risk: A multicenter study. Clin. Nutr.. 2025; 53: 46029. DOI: 10.1016/j.clnu.2025.08.010. 28. Hu Q,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Oncological impact of unexpected horizontal tumour spread in oesophagogastric junction cancer. BJS Open. 2025; 9(5): 46031. DOI: 10.1093/bjsopen/zraf119. 29. Yamagata Y,Furuta M,Notsu A,Yasui H,Makuuchi R,Yamada T,Ishida M,Tsuji K,Baba S,Tokumoto N,Haruta S,Watanabe M,Hamakawa T,Kawachi Y,Sugisawa N,Yabusaki H,Kawabata R,Kurokawa Y,Boku N,Terashima M,Machida N,Yoshikawa T. Efficacy of nodal dissection for locoregional gastric neuroendocrine carcinoma: a multicenter retrospective observational study. Gastric Cancer. 2025; 28(5): 1004-1016. DOI: 10.1007/s10120-025-01636-4. 30. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Preoperative low prealbumin independently predicts non-gastric cancer death after gastrectomy in elderly and young patients: a retrospective cohort study. Surg. Today. 2025; 55(8): 1068-1078. DOI: 10.1007/s00595-025-02996-1. 31. Hayami M,Ohashi M,Ri M,Makuuchi R,Irino T,Sano T,Nunobe S. Maintenance of resection margins in gastrectomy for cancer: simple in procedure, influential in survival-current status and literature review on optimal lengths and positive margins. Surg. Today. 2025; 55(8): 1013-1023. DOI: 10.1007/s00595-025-03068-0. 32. Matsui R,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Prognostic impact of postoperative fixed-point inflammation in patients with gastric cancer after curative gastrectomy: A validation cohort study. Ann. Gastroenterol. Surg.. 2025; 9(4): 698-710. DOI: 10.1002/ags3.70006. 33. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Elevated prealbumin levels after preoperative nutritional intervention is an independent prognostic factor for overall survival after radical gastrectomy in patients with gastric cancer and severe malnutrition. Langenbecks Arch. Surg.. 2025; 410(1): 206. DOI: 10.1007/s00423-025-03785-7. 34. Matsui R,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Oncological impact of the preoperative combined assessment of skeletal muscle mass for patients undergoing curative gastrectomy for gastric cancer. Surg. Today. 2025; 55(7): 875-885. DOI: 10.1007/s00595-024-02978-9. 35. Matsui R,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Worse oncological impact of preoperative anemia in patients with locally advanced gastric cancer after curative gastrectomy: A retrospective cohort study. Eur. J. Surg. Oncol.. 2025; 51(7): 109762. DOI: 10.1016/j.ejso.2025.109762. 36. Hu Q,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Minimum resection length to ensure a pathologically negative distal margin and a larger remnant stomach for esophagogastric junction cancer. Gastric Cancer. 2025; 28(3): 493-500. DOI: 10.1007/s10120-025-01581-2. 37. Ri M,Hayami M,Ohashi M,Makuuchi R,Irino T,Sano T,Nunobe S. Possibly more favorable short-term outcomes with minimally invasive surgery than with open surgery in total gastrectomy for locally advanced gastric cancer: A single high-volume center study. Ann. Gastroenterol. Surg.. 2025; 9(3): 439-447. DOI: 10.1002/ags3.12881. 38. Terayama M,Kumagai K,Ri M,Makuuchi R,Hayami M,Ida S,Ohashi M,Sano T,Nunobe S. Feasibility of a "stomach-preserving strategy" for perforated gastric cancer in patients with distant metastasis. In Vivo. 2025; 39(2): 969-975. DOI: 10.21873/invivo.13902. 39. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Post-radical gastrectomy long-term survival and etiologies of mortalities in older adult patients greater than 80 years of age with gastric cancer. World J. Surg.. 2025; 49(1): 230-240. DOI: 10.1002/wjs.12405. 40. Irino T,Ohashi M,Hayami M,Makuuchi R,Ri M,Sano T,Yamaguchi T,Nunobe S. Updated review of proximal gastrectomy for gastric cancer or cancer of the gastroesophageal junction. J. Gastric Cancer. 2025; 25(1): 228-246. DOI: 10.5230/jgc.2025.25.e12. 41. Terayama M,Ohashi M,Yamaguchi K,Takahari D,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. Feasibility and predictive factors on the completion of docetaxel plus S-1 adjuvant chemotherapy in pathological stage III gastric cancer. Ann. Gastroenterol. Surg.. 2025; 9(1): 60-68. DOI: 10.1002/ags3.12840. 42. Ri M,Nishie N,Ohashi M,Fukuoka S,Yamaguchi K,Makuuchi R,Hayami M,Irino T,Sano T,Nunobe S. Advantages of adjuvant chemotherapy using S-1 following minimally invasive gastrectomy for gastric cancer versus open surgery: a propensity score-matched analysis. Gastric Cancer. 2025; 28(1): 122-130. DOI: 10.1007/s10120-024-01565-8. 43. Terayama M,Ohashi M,Ri M,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. Possible muscle-sparing advantage and bodyweight maintenance of laparoscopic gastrectomy for older patients with locally advanced gastric cancer. Langenbecks Arch. Surg.. 2024; 409(1): 365. DOI: 10.1007/s00423-024-03554-y. 44. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Prealbumin prognostic score: A novel prognostic indicator after radical gastrectomy in patients with gastric cancer. Cancers (Basel). 2024; 16(22): 3889. DOI: 10.3390/cancers16223889. 45. Hu Q,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Safety of robotic double-flap technique following proximal gastrectomy in the introductory phase compared with laparoscopic procedure: a propensity score-matched analysis. Surg. Endosc.. 2024; 38(10): 5824-5831. DOI: 10.1007/s00464-024-11156-4. 46. Yamaguchi T,Kumagai K,Yagi S,Nomura T,Nagashima K,Watanabe M,Makuuchi R,Kawakami K,Matsushima T,Kadowaki S,Haruta S,Cho H,Kakihara N,Otsuka S,Yamada T,Imai Y,Boku N. Efficacy of chemotherapy for patients with gastric cancer with early recurrence during or after adjuvant chemotherapy with S-1 alone: a multicenter retrospective study. Sci. Rep.. 2024; 14(1): 21854. DOI: 10.1038/s41598-024-72423-x. 47. Kumagai K,Yoshida M,Ishida H,Ishizuka N,Ohashi M,Makuuchi R,Hayami M,Ida S,Yoshimizu S,Horiuchi Y,Ishiyama A,Yoshio T,Hirasawa T,Fujisaki J,Nunobe S. Diagnostic performance of near-infrared fluorescent marking clips in laparoscopic gastrectomy. J. Surg. Res.. 2024; 300: 157-164. DOI: 10.1016/j.jss.2024.05.003. 48. Izumi D,Nunobe S,Ishizuka N,Yagi T,Hayami M,Makuuchi R,Ohashi M,Watanabe M,Sano T. Identification of the factor affecting learning curves of laparoscopic gastrectomy through the experience at a Japanese high-volume center over the last decade. Ann. Gastroenterol. Surg.. 2024; 8(4): 604-610. DOI: 10.1002/ags3.12782. 49. Harada H,Eto K,Ohashi M,Kurihara N,Ri M,Makuuchi R,Ida S,Hayami M,Kumagai K,Sano T,Nunobe S. Equal short-term outcomes of intracorporeal mechanical gastrogastrostomy in laparoscopic pylorus-preserving gastrectomy for cT1N0 gastric cancer in the middle stomach compared with the extracorporeal hand-sewing method. Surg. Endosc.. 2024; 38(6): 3115-3125. DOI: 10.1007/s00464-024-10823-w. 50. Matsui R,Ida S,Ri M,Makuuchi R,Hayami M,Kumagai K,Ohashi M,Sano T,Nunobe S. Impact of preoperative prealbumin levels on long-term prognosis in patients with gastric cancer after gastrectomy: a retrospective cohort study. Gastric Cancer. 2024; 27(3): 611-621. DOI: 10.1007/s10120-024-01472-y. 51. Ri M,Ohashi M,Makuuchi R,Hayami M,Sano T,Nunobe S. Clinical impact of polyglycolic acid mesh to reduce pancreas-related complications after minimally invasive surgery for gastric cancer: A propensity score matching analysis. J. Gastric Cancer. 2024; 24(2): 220-230. DOI: 10.5230/jgc.2024.24.e17. 52. Terayama M,Ohashi M,Ri M,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. Long-term impact of sarcopenia in older patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis. Transl. Gastroenterol. Hepatol.. 2023; 8: 35. DOI: 10.21037/tgh-23-34. 53. Oba A,Maekawa A,Inoue Y,Makuuchi R,Omiya K,Kobayashi K,Ono Y,Sato T,Ohashi M,Ito H,Nunobe S,Takahashi Y. Robotic splenic vessels preserving distal pancreatectomy in a post-distal gastrectomy patient. Ann. Surg. Oncol.. 2023; 30(11): 6680-6681. DOI: 10.1245/s10434-023-13802-y. 54. Oba A,Maekawa A,Makuuchi R,Inoue Y,Takahashi Y. ASO author reflections: Open/robotic-splenic vessels preserving distal pancreatectomy can be a good option for post-distal gastrectomy patients. Ann. Surg. Oncol.. 2023; 30(11): 6682-6683. DOI: 10.1245/s10434-023-13837-1. 55. Matsui R,Nunobe S,Makuuchi R,Hayami M,Ida S,Kumagai K,Ohashi M,Sano T. Relationship between antithrombotic drugs and postoperative outcomes in patients with gastric cancer after gastrectomy: a propensity matching analysis. Gastric Cancer. 2023; 26(5): 833-842. DOI: 10.1007/s10120-023-01410-4. 56. Koterazawa Y,Ohashi M,Hayami M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Oncological impact of unexpected horizontal tumor spread in gastric cancer that requires total gastrectomy. Gastric Cancer. 2023; 26(5): 823-832. DOI: 10.1007/s10120-023-01401-5. 57. Kumagai K,Nunobe S,Hiki N,Hayami M,Ishizuka N,Ida S,Makuuchi R,Jiang X,Ohashi M,Sano T. Anatomical position of the pancreas as a risk factor for pancreatic fistula after laparoscopic gastrectomy for gastric cancer. World J. Surg.. 2023; 47(7): 1744-1751. DOI: 10.1007/s00268-023-06972-z. 58. Kumagai K,Nunobe S,Hiki N,Hayami M,Ishizuka N,Ida S,Makuuchi R,Jiang X,Ohashi M,Sano T. Anatomical position of the pancreas as a risk factor for pancreatic fistula after laparoscopic gastrectomy for gastric cancer. World J. Surg.. 2023; 47(7): 1744-1751. DOI: 10.1007/s00268-023-06972-z. 59. Terayama M,Kumagai K,Kawachi H,Makuuchi R,Hayami M,Ida S,Ohashi M,Sano T,Nunobe S. Optimal resection of gastric bronchogenic cysts based on anatomical continuity with adherent gastric muscular layer: A case report. World J. Gastrointest. Surg.. 2023; 15(6): 1216-1223. DOI: 10.4240/wjgs.v15.i6.1216. 60. Koterazawa Y,Ohashi M,Hayami M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Required esophageal resection length beyond the tumor boundary to ensure a negative proximal margin for gastric cancer with gross esophageal invasion or esophagogastric junction cancer. Gastric Cancer. 2023; 26(3): 451-459. DOI: 10.1007/s10120-023-01369-2. 61. Harada H,Hayami M,Makuuchi R,Ida S,Kumagai K,Ohashi M,Nunobe S. A sandwiching method that simplifies hepatic left lateral segment inversion to secure an optimal surgical view around the esophageal hiatus in laparoscopic and robotic gastrectomy for upper gastric and esophagogastric junction cancers. Langenbecks Arch. Surg.. 2023; 408(1): 159. DOI: 10.1007/s00423-023-02901-9. 62. Otake R,Kumagai K,Ohashi M,Makuuchi R,Ida S,Sano T,Nunobe S. ASO author reflections: Severe reflux esophagitis after laparoscopic pylorus-preserving gastrectomy for gastric cancer is associated with male sex, preoperative grade A reflux esophagitis, postoperative BMI of ≥23 kg/m2, hiatal hernia, and long-term gastric stasis. Ann. Surg. Oncol.. 2023; 30(4): 2304-2305. DOI: 10.1245/s10434-022-12949-4. 63. Otake R,Kumagai K,Ohashi M,Makuuchi R,Ida S,Sano T,Nunobe S. Reflux esophagitis after laparoscopic pylorus-preserving gastrectomy for gastric cancer. Ann. Surg. Oncol.. 2023; 30(4): 2294-2303. DOI: 10.1245/s10434-022-12902-5. 64. Terayama M,Ohashi M,Ida S,Hayami M,Makuuchi R,Kumagai K,Sano T,Nunobe S. Advantages of function-preserving gastrectomy for older patients with upper-third early gastric cancer: Maintenance of nutritional status and favorable survival. J. Gastric Cancer. 2023; 23(2): 303-314. DOI: 10.5230/jgc.2023.23.e9. 65. Yagi S,Ida S,Namikawa K,Hayami M,Makuuchi R,Kumagai K,Ohashi M,Sano T,Nunobe S. Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer. Surg. Today. 2023; 53(3): 360-368. DOI: 10.1007/s00595-022-02567-8. 66. Yagi S,Ida S,Namikawa K,Hayami M,Makuuchi R,Kumagai K,Ohashi M,Sano T,Nunobe S. Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer. Surg. Today. 2023; 53(3): 360-368. DOI: 10.1007/s00595-022-02567-8. 67. Terayama M,Ohashi M,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. A continuous muscle-sparing advantage of pylorus-preserving gastrectomy for older patients with cT1N0M0 gastric cancer in the middle third of the stomach. Gastric Cancer. 2023; 26(1): 145-154. DOI: 10.1007/s10120-022-01345-2. 68. Inoue Y,Sato T,Kato T,Oba A,Ono Y,Ito H,Makuuchi R,Takahashi Y. How can we optimize surgical view during robotic-assisted pancreaticoduodenectomy? Feasibility of multiple scope transition method. J. Am. Coll. Surg.. 2022; 235(4): e1-e7. DOI: 10.1097/XCS.0000000000000281. 69. Koterazawa Y,Ohashi M,Hayami M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Minimum resection length to ensure a pathologically negative distal margin and the preservation of a larger remnant stomach in proximal gastrectomy for early upper gastric cancer. Gastric Cancer. 2022; 25(5): 973-981. DOI: 10.1007/s10120-022-01304-x. 70. Harada H,Ohashi M,Hiki N,Fujisaki J,Hirasawa T,Yamamoto Y,Makuuchi R,Ida S,Hayami M,Kumagai K,Sano T,Nunobe S. Excellent oncological outcomes besides short-term safety of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor. Endosc. Int. Open. 2022; 10(9): E1254-E1260. DOI: 10.1055/a-1895-9507. 71. Yasufuku I,Ohashi M,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy. Eur. J. Surg. Oncol.. 2022; 48(8): 1746-1752. DOI: 10.1016/j.ejso.2022.01.011. 72. Nishie N,Ohashi M,Makuuchi R,Hayami M,Ida S,Kumagai K,Nunobe S,Sano T. Successful open radical gastrectomy for locally advanced or metastatic gastric cancer patients who suffered from coronavirus disease 2019 during preoperative chemotherapy: a report of three cases. Surg. Case Rep.. 2022; 8(1): 124. DOI: 10.1186/s40792-022-01465-y. 73. Izumi D,Ida S,Hayami M,Makuuchi R,Kumagai K,Ohashi M,Watanabe M,Sano T,Nunobe S. Increased rate of serum prealbumin level after preoperative enteral nutrition as an indicator of morbidity in gastrectomy for gastric cancer with outlet obstruction. World J. Surg.. 2022; 46(3): 624-630. DOI: 10.1007/s00268-021-06384-x. 74. Muneoka Y,Ohashi M,Ishizuka N,Hayami M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection?. Gastric Cancer. 2022; 25(1): 287-296. DOI: 10.1007/s10120-021-01238-w. 75. Shoji Y,Nunobe S,Nishie N,Yagi S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Ishiyama A,Yoshio T,Hirasawa T,Fujisaki J,Sano T. Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy. Endosc. Int. Open. 2022; 10(1): E62-E73. DOI: 10.1055/a-1635-5855. 76. Ri M,Nunobe S,Ida S,Ishizuka N,Atsumi S,Hayami M,Makuuchi R,Kumagai K,Ohashi M,Sano T. Postprandial asymptomatic glycemic fluctuations after gastrectomy for gastric cancer using continuous glucose monitoring device. J. Gastric Cancer. 2021; 21(4): 325-334. DOI: 10.5230/jgc.2021.21.e31. 77. Kano Y,Ohashi M,Muneoka Y,Takahari D,Chin K,Yamaguchi K,Ida S,Kumagai K,Makuuchi R,Sano T,Nunobe S. Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy. Eur. J. Surg. Oncol.. 2021; 47(12): 3097-3104. DOI: 10.1016/j.ejso.2021.04.018. 78. Ri M,Kumagai K,Namikawa K,Atsumi S,Hayami M,Makuuchi R,Ida S,Ohashi M,Sano T,Nunobe S. Is proximal gastrectomy indicated for locally advanced cancer in the upper third of the stomach?. Ann. Gastroenterol. Surg.. 2021; 5(6): 767-775. DOI: 10.1002/ags3.12486. 79. Ri M,Ohashi M,Eto K,Ishizuka N,Atsumi S,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Favorable outcomes of neoadjuvant chemotherapy and limited para-aortic lymph node dissection for advanced gastric cancer with para-aortic lymph node metastasis. World J. Surg.. 2021; 45(9): 2849-2859. DOI: 10.1007/s00268-021-06184-3. 80. Muneoka Y,Ohashi M,Kurihara N,Fujisaki J,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Short- and long-term oncological outcomes of totally laparoscopic gastrectomy versus laparoscopy-assisted gastrectomy for clinical stage I gastric cancer. Gastric Cancer. 2021; 24(5): 1140-1149. DOI: 10.1007/s10120-021-01181-w. 81. Muneoka Y,Ohashi M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Advantageous short-term outcomes of esophagojejunostomy using a linear stapler following open total gastrectomy compared with a circular stapler. World J. Surg.. 2021; 45(8): 2501-2509. DOI: 10.1007/s00268-021-06100-9. 82. Ri M,Nunobe S,Ida S,Ishizuka N,Atsumi S,Makuuchi R,Kumagai K,Ohashi M,Sano T. Preliminary prospective study of real-time post-gastrectomy glycemic fluctuations during dumping symptoms using continuous glucose monitoring. World J. Gastroenterol.. 2021; 27(23): 3386-3395. DOI: 10.3748/wjg.v27.i23.3386. 83. Ri M,Nunobe S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Key factors for maintaining postoperative skeletal muscle mass after laparoscopic proximal gastrectomy with double-flap technique reconstruction for early gastric cancer. J. Gastrointest. Surg.. 2021; 25(6): 1569-1572. DOI: 10.1007/s11605-020-04846-6. 84. Ri M,Nunobe S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Is laparoscopic and endoscopic cooperative surgery (LECS) for gastric subepithelial tumor at the esophagogastric junction safe?. Asian J. Endosc. Surg.. 2021; 14(2): 223-231. DOI: 10.1111/ases.12857. 85. Kumagai K,Hiki N,Nunobe S,Jiang X,Makuuchi R,Ida S,Ohashi M,Yamaguchi T,Sano T. Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high-volume center. Surg. Endosc.. 2021; 35(4): 1834-1842. DOI: 10.1007/s00464-020-07584-7. 86. Kumagai K,Hiki N,Nunobe S,Jiang X,Makuuchi R,Ida S,Ohashi M,Yamaguchi T,Sano T. Correction to: Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high‑volume center. Surg. Endosc.. 2021; 35(4): 1843. DOI: 10.1007/s00464-020-07774-3. 87. Takahashi R,Nunobe S,Sai N,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Pancreatic atrophy after gastrectomy for gastric cancer. Surg. Today. 2021; 51(3): 432-438. DOI: 10.1007/s00595-020-02131-2. 88. Yagi S,Nunobe S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Oncological outcomes in patients with pT1N0-3 or pT2-3N0 gastric cancer after curative resection without adjuvant chemotherapy. Langenbecks Arch. Surg.. 2021; 406(2): 419-426. DOI: 10.1007/s00423-021-02084-1. 89. Honda S,Furukawa K,Makuuchi R,Irino T,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Shinsato K,Matsumoto T,Terashima M. A phase II study of ramelteon for the prevention of postoperative delirium in elderly patients undergoing gastrectomy. Surg. Today. 2020; 50(12): 1681-1686. DOI: 10.1007/s00595-020-02073-9. 90. Kaji S,Irino T,Kusuhara M,Makuuchi R,Yamakawa Y,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Kami K,Ohashi Y,Zhang S,Orita H,Lee-Okada HC,Fukunaga T,Terashima M. Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence. Gastric Cancer. 2020; 23(5): 874-883. DOI: 10.1007/s10120-020-01065-5. 91. Kano Y,Ohashi M,Ida S,Kumagai K,Makuuchi R,Sano T,Hiki N,Nunobe S. Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types. Gastric Cancer. 2020; 23(5): 927-936. DOI: 10.1007/s10120-020-01072-6. 92. Takahashi R,Ohashi M,Hiki N,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Risk factors and prognosis of gastric stasis, a crucial problem after laparoscopic pylorus-preserving gastrectomy for early middle-third gastric cancer. Gastric Cancer. 2020; 23(4): 707-715. DOI: 10.1007/s10120-019-01037-4. 93. Takahashi R,Nunobe S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Survival outcomes of elderly patients with pathological stages II and III gastric cancer following curative gastrectomy. Ann. Gastroenterol. Surg.. 2020; 4(4): 433-440. DOI: 10.1002/ags3.12339. 94. Yamaguchi T,Takashima A,Nagashima K,Makuuchi R,Aizawa M,Ohashi M,Tashiro K,Yamada T,Kinoshita T,Hata H,Kawachi Y,Kawabata R,Tsuji T,Hihara J,Sakamoto T,Fukagawa T,Katai H,Higuchi K,Boku N. Efficacy of postoperative chemotherapy after resection that leaves no macroscopically visible disease of Gastric Cancer with positive peritoneal lavage cytology (CY1) or localized peritoneum metastasis (P1a): A multicenter retrospective study. Ann. Surg. Oncol.. 2020; 27(1): 284-292. DOI: 10.1245/s10434-019-07697-x. 95. Waki Y,Irino T,Makuuchi R,Notsu A,Kamiya S,Tanizawa Y,Bando E,Kawamura T,Terashima M. Impact of preoperative skeletal muscle quality measurement on long-term survival after curative gastrectomy for locally advanced gastric cancer. World J. Surg.. 2019; 43(12): 3083-3093. DOI: 10.1007/s00268-019-05145-1. 96. Fujiya K,Irino T,Furukawa K,Omori H,Makuuchi R,Tanizawa Y,Bando E,Terashima M. Safety of prolonged wait time for gastrectomy in clinical stage I gastric cancer. Eur. J. Surg. Oncol.. 2019; 45(10): 1964-1968. DOI: 10.1016/j.ejso.2019.06.006. 97. Matsubayashi H,Matsui T,Sugiura T,Makuuchi R,Kaneko J,Satoh J,Satoh T,Fujie S,Ishiwatari H,Sasaki K,Ono H. A large carcinosarcoma of the gallbladder accompanied by pancreaticobiliary maljunction: A case with a six-year survival. Intern. Med.. 2019; 58(19): 2809-2817. DOI: 10.2169/internalmedicine.2783-19. 98. Furukawa K,Irino T,Makuuchi R,Koseki Y,Nakamura K,Waki Y,Fujiya K,Omori H,Tanizawa Y,Bando E,Kawamura T,Terashima M. Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer. Gastric Cancer. 2019; 22(4): 864-872. DOI: 10.1007/s10120-018-00910-y. 99. Asaoka R,Kawamura T,Makuuchi R,Irino T,Tanizawa Y,Bando E,Terashima M. Risk factors for 30-day hospital readmission after radical gastrectomy: a single-center retrospective study. Gastric Cancer. 2019; 22(2): 413-420. DOI: 10.1007/s10120-018-0856-4. 100. Omori H,Tanizawa Y,Makuuchi R,Irino T,Bando E,Kawamura T,Terashima M. Role of palliative resection in patients with incurable advanced gastric cancer who are unfit for chemotherapy. World J. Surg.. 2019; 43(2): 571-579. DOI: 10.1007/s00268-018-4816-2. 101. Asaoka R,Irino T,Makuuchi R,Tanizawa Y,Bando E,Kawamura T,Terashima M. Changes in body weight, skeletal muscle and adipose tissue after gastrectomy: a comparison between proximal gastrectomy and total gastrectomy. ANZ J. Surg.. 2019; 89(46024): 79-83. DOI: 10.1111/ans.15023. 102. Honda S,Furukawa K,Nishiwaki N,Fujiya K,Omori H,Kaji S,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Risk factors for postoperative delirium after gastrectomy in gastric cancer patients. World J. Surg.. 2018; 42(11): 3669-3675. DOI: 10.1007/s00268-018-4682-y. 103. Fujiya K,Tokunaga M,Nishiwaki N,Furukawa K,Omori H,Kaji S,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Feasibility of laparoscopic distal gastrectomy for stage I gastric cancer in patients outside of clinical trials. J. Gastrointest. Surg.. 2018; 22(10): 1665-1671. DOI: 10.1007/s11605-018-3842-6. 104. Hikage M,Tokunaga M,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Reply to comment on "Are body mass index and performance status enough to assess the nutritional and functional status of elderly patients undergoing gastric cancer surgery?". Surg. Today. 2018; 48(12): 1102-1103. DOI: 10.1007/s00595-018-1702-3. 105. Hikage M,Tokunaga M,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Surgical outcomes after gastrectomy in very elderly patients with gastric cancer. Surg. Today. 2018; 48(8): 773-782. DOI: 10.1007/s00595-018-1651-x. 106. Hikage M,Tokunaga M,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Comparison of surgical outcomes between robotic and laparoscopic distal gastrectomy for cT1 gastric cancer. World J. Surg.. 2018; 42(6): 1803-1810. DOI: 10.1007/s00268-017-4345-4. 107. Fujiya K,Kawamura T,Omae K,Makuuchi R,Irino T,Tokunaga M,Tanizawa Y,Bando E,Terashima M. Impact of malnutrition after gastrectomy for gastric cancer on long-term survival. Ann. Surg. Oncol.. 2018; 25(4): 974-983. DOI: 10.1245/s10434-018-6342-8. 108. Fujiya K,Takizawa K,Tokunaga M,Kawata N,Hikage M,Makuuchi R,Tanizawa Y,Bando E,Kawamura T,Tanaka M,Kakushima N,Ono H,Terashima M. The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer. Gastric Cancer. 2018; 21(1): 124-132. DOI: 10.1007/s10120-017-0724-7. 109. Furukawa K,Tanizawa Y,Kusafuka K,Nishiwaki N,Fujiya K,Omori H,Kaji S,Hikage M,Makuuchi R,Irino T,Tokunaga M,Bando E,Kawamura T,Terashima M. Amputation neuroma mimicking lymph node metastasis of remnant gastric cancer: a case report. Surg. Case Rep.. 2017; 3(1): 123. DOI: 10.1186/s40792-017-0396-x. 110. Tanizawa Y,Bando E,Kawamura T,Tokunaga M,Makuuchi R,Iida K,Nanri K,Yoneyama M,Terashima M. Prevalence of deep venous thrombosis detected by ultrasonography before surgery in patients with gastric cancer: a retrospective study of 1140 consecutive patients. Gastric Cancer. 2017; 20(5): 878-886. DOI: 10.1007/s10120-016-0677-2. 111. Honda S,Bando E,Makuuchi R,Tokunaga M,Tanizawa Y,Kawamura T,Sugiura T,Kinugasa Y,Uesaka K,Terashima M. Effects of initial disease status on lymph flow following gastrectomy in cases of carcinoma in the remnant stomach. Gastric Cancer. 2017; 20(3): 457-464. DOI: 10.1007/s10120-016-0640-2. 112. Kawata N,Kakushima N,Takizawa K,Tanaka M,Makuuchi R,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Sugino T,Kusafuka K,Shimoda T,Nakajima T,Terashima M,Ono H. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection. Surg. Endosc.. 2017; 31(4): 1607-1616. DOI: 10.1007/s00464-016-5148-7. 113. Fujiya K,Tokunaga M,Makuuchi R,Nishiwaki N,Omori H,Takagi W,Hirata F,Hikage M,Tanizawa Y,Bando E,Kawamura T,Terashima M. Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer. Gastric Cancer. 2017; 20(Suppl 1): 141-149. DOI: 10.1007/s10120-016-0661-x. 114. Yamashita H,Seto Y,Sano T,Makuuchi H,Ando N,Sasako M,Japanese Gastric Cancer Association and the Japan Esophageal Society. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017; 20(Suppl 1): 69-83. DOI: 10.1007/s10120-016-0663-8. 115. Hikage M,Tokunaga M,Makuuchi R,Tanizawa Y,Bando E,Kawamura T,Terashima M. Impact of an ultrasonically activated device in robot-assisted distal gastrectomy. Innovations (Phila.). 2017; 12(6): 453-458. DOI: 10.1097/IMI.0000000000000437. 116. Fujiya K,Tokunaga M,Mori K,Makuuchi R,Tanizawa Y,Bando E,Kawamura T,Terashima M. Long-term survival in patients with postoperative intra-abdominal infectious complications after curative gastrectomy for gastric cancer: A propensity score matching analysis. Ann. Surg. Oncol.. 2016; 23(Suppl 5): 809-816. DOI: 10.1245/s10434-016-5577-5. 117. Yoshida M,Sugino T,Kusafuka K,Nakajima T,Makuuchi R,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Terashima M,Kawata N,Tanaka M,Kakushima N,Takizawa K,Ono H. Peritoneal dissemination in early gastric cancer: importance of the lymphatic route. Virchows Arch.. 2016; 469(2): 155-161. DOI: 10.1007/s00428-016-1960-7. 118. Sugisawa N,Tokunaga M,Makuuchi R,Miki Y,Tanizawa Y,Bando E,Kawamura T,Terashima M. A phase II study of an enhanced recovery after surgery protocol in gastric cancer surgery. Gastric Cancer. 2016; 19(3): 961-967. DOI: 10.1007/s10120-015-0528-6. 119. Terashima M,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Miki Y,Makuuchi R,Honda S,Tatsubayashi T,Takagi W,Omori H,Hirata F. Robotic surgery for gastric cancer. Gastric Cancer. 2015; 18(3): 449-457. DOI: 10.1007/s10120-015-0501-4. 120. Miki Y,Kawamura T,Sugisawa N,Makuuchi R,Nakajima T,Tokunaga M,Tanizawa Y,Bando E,Terashima M. Risk classification using the Ki-67 labeling index for surgically-treated gastric gastrointestinal stromal tumors. Hepatogastroenterology. 2015; 62(140): 919-923. 121. Goto H,Tokunaga M,Miki Y,Makuuchi R,Sugisawa N,Tanizawa Y,Bando E,Kawamura T,Niihara M,Tsubosa Y,Terashima M. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric Cancer. 2014; 18(2): 375-381. DOI: 10.1007/s10120-014-0364-0. 122. Mine S,Udagawa H,Kinoshita Y,Makuuchi R. Post-esophagectomy chylous leakage from a duplicated left-sided thoracic duct ligated successfully with left-sided video-assisted thoracoscopic surgery. Interact. Cardiovasc. Thorac. Surg.. 2008; 7(6): 1186-1188. DOI: 10.1510/icvts.2008.185306.

研究テーマ

胃癌の手術治療

研究業績（論文）

1. Makuuchi R,Nunobe S,Ishizuka N,Atsumi S,Shoji Y,Ri M,Hayami M,Irino T,Ohashi M,Sano T. Prospective feasibility study of laparoscopic and robotic distal gastrectomy for advanced gastric cancer to verify the safety of surgical proximal margins. Ann. Gastroenterol. Surg.. 2025; (ags3.70141): . DOI: 10.1002/ags3.70141.
2. Makuuchi R,Terashima M,Terada M,Mizusawa J,Kita R,Tokunaga M,Omori T,Ojima T,Ehara K,Watanabe M,Yanagimoto Y,Nunobe S,Kinoshita T,Ito S,Nishida Y,Hihara J,Boku N,Kurokawa Y,Yoshikawa T,Stomach Cancer Study Group of Japan Clinical Oncology Group. Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol. BMC Cancer. 2023; 23(1): 987. DOI: 10.1186/s12885-023-11481-2.
3. Makuuchi R,Kamiya S,Tanizawa Y,Bando E,Terashima M. Robotic surgery for gastric cancer. Mini-invasive Surg.. 2019; 2019: . DOI: 10.20517/2574-1225.2019.03.
4. Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Esophagojejunal anastomotic leakage following gastrectomy for gastric cancer. Surg. Today. 2019; 49(3): 187-196. DOI: 10.1007/s00595-018-1726-8.
5. Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Pancreaticoduodenectomy for gastric cancer. J. Cancer Metastasis Treat.. 2018; 4(6): 26. DOI: 10.20517/2394-4722.2018.15.
6. Makuuchi R,Sugisawa N,Kaji S,Hikage M,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Terashima M. Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading. Eur. J. Surg. Oncol.. 2017; 43(1): 210-217. DOI: 10.1016/j.ejso.2016.07.140.
7. Makuuchi R,Terashima M,Kusuhara M,Nakajima T,Serizawa M,Hatakeyama K,Ohshima K,Urakami K,Yamaguchi K. Comprehensive analysis of gene mutation and expression profiles in neuroendocrine carcinomas of the stomach. Biomed. Res.. 2017; 38(1): 19-27. DOI: 10.2220/biomedres.38.19.
8. Honda M,Makuuchi R,Nunobe S,Yamabuki T,Ogawa K,Akashi Y,Bamba T,Aizawa M,Waragai M,Hori S,Yamagata Y,Yoshikawa T. Surgical manipulation related to the risk of postoperative complications in laparoscopic gastrectomy: a case-control study assessing full surgical videos. Surg. Endosc.. 2025; 39(4): 2406-2414. DOI: 10.1007/s00464-025-11605-8.
9. Kaji S,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Omori H,Fujiya K,Nishiwaki N,Furukawa K,Nakamura K,Koseki Y,Waki Y,Asaoka R,Terashima M. Preventive effect on delayed gastric emptying of preserving the infra-pyloric vein in laparoscopic pylorus-preserving gastrectomy for early gastric cancer. Surg. Endosc.. 2020; 34(9): 3853-3860. DOI: 10.1007/s00464-019-07151-9.
10. Toriumi T,Makuuchi R,Kamiya S,Tanizawa Y,Bando E,Terashima M. Obesity is a risk factor for internal hernia after laparoscopic or robot-assisted gastrectomy with mesenteric defect closure for gastric cancer. Surg. Endosc.. 2020; 34(1): 436-442. DOI: 10.1007/s00464-019-06787-x.
11. Bando E,Makuuchi R,Irino T,Tanizawa Y,Kawamura T,Terashima M. Validation of the prognostic impact of the new tumor-node-metastasis clinical staging in patients with gastric cancer. Gastric Cancer. 2019; 22(1): 123-129. DOI: 10.1007/s10120-018-0799-9.
12. Waki Y,Makuuchi R,Nagata M,Furukawa K,Fujiya K,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. The current status and future perspective about robotic surgery for gastric cancer. Gan To Kagaku Ryoho. 2018; 45(12): 1690-1695.
13. Kawamura T,Makuuchi R,Tokunaga M,Tanizawa Y,Bando E,Yasui H,Aoyama T,Inano T,Terashima M. Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann. Surg. Oncol.. 2018; 25(6): 1625-1632. DOI: 10.1245/s10434-018-6452-3.
14. Miki Y,Makuuchi R,Honda S,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Yurikusa T,Tanuma A,Terashima M. Prospective phase II study evaluating the efficacy of swallow ability screening tests and pneumonia prevention using a team approach for elderly patients with gastric cancer. Gastric Cancer. 2018; 21(2): 353-359. DOI: 10.1007/s10120-017-0736-3.
15. Bando E,Makuuchi R,Tokunaga M,Tanizawa Y,Kawamura T,Terashima M. Impact of clinical tumor-node-metastasis staging on survival in gastric carcinoma patients receiving surgery. Gastric Cancer. 2017; 20(3): 448-456. DOI: 10.1007/s10120-016-0637-x.
16. Tokunaga M,Makuuchi R,Miki Y,Tanizawa Y,Bando E,Kawamura T,Terashima M. Late phase II study of robot-assisted gastrectomy with nodal dissection for clinical stage I gastric cancer. Surg. Endosc.. 2016; 30(8): 3362-3367. DOI: 10.1007/s00464-015-4613-z.
17. Miki Y,Makuuchi R,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Terashima M. Risk factors for postoperative pneumonia after gastrectomy for gastric cancer. Surg. Today. 2016; 46(5): 552-556. DOI: 10.1007/s00595-015-1201-8.
18. Tokunaga M,Makuuchi R,Miki Y,Tanizawa Y,Bando E,Kawamura T,Terashima M. Surgical and survival outcome following truly palliative gastrectomy in patients with incurable gastric cancer. World J. Surg.. 2016; 40(5): 1172-1177. DOI: 10.1007/s00268-015-3398-5.
19. Oba A,Shimane G,Makuuchi R,Kiritani S,Kobayashi K,Ri M,Ono Y,Hayami M,Irino T,Ito H,Inoue Y,Ohashi M,Nunobe S,Takahashi Y. ASO visual abstract: Robotic pancreatectomy as an adjunct to radical gastrectomy for advanced gastric cancer: Surgical and clinical implications. Ann. Surg. Oncol.. 2026; : . DOI: 10.1245/s10434-026-19168-1.
20. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Low preoperative prealbumin increases non-gastric cancer mortality in patients with early or advanced gastric cancer after gastrectomy: a retrospective cohort study. Surg. Today. 2026; 56(2): 152-164. DOI: 10.1007/s00595-025-03112-z.
21. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Preoperative prealbumin levels are prognostic predictors of overall survival, independent of inflammation severity, in patients with gastric cancer following gastrectomy. Surg. Today. 2026; : 46037. DOI: 10.1007/s00595-025-03164-1.
22. Kumagai K,Yoshida M,Ishida H,Ishizuka N,Ohashi M,Makuuchi R,Hayami M,Ida S,Ikenoyama Y,Namikawa K,Tokai Y,Yoshimizu S,Horiuchi Y,Ishiyama A,Yoshio T,Hirasawa T,Fujisaki J,Nunobe S. Utility and safety of near-infrared fluorescent marking clips for tumor localization in robot-assisted laparoscopic gastric cancer surgery. J. Gastrointest. Surg.. 2026; 30(1): 102280. DOI: 10.1016/j.gassur.2025.102280.
23. Sugita Y,Ohashi M,Miyazaki N,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Optimal cutoff size of large Borrmann type III gastric cancer: Is 8 cm accurate in predicting survival and incidence of peritoneal metastasis?. Ann. Gastroenterol. Surg.. 2026; 10(1): 77-86. DOI: 10.1002/ags3.70071.
24. Hayami M,Hu Q,Ri M,Makuuchi R,Irino T,Sano T,Nunobe S. Non-flap tunnel technique (NFTT): A novel minimally invasive reconstruction method after proximal gastrectomy for gastric and esophagogastric junction cancer. Ann. Gastroenterol. Surg.. 2026; 10(1): 87-94. DOI: 10.1002/ags3.70072.
25. Oba A,Shimane G,Makuuchi R,Kiritani S,Kobayashi K,Ri M,Ono Y,Hayami M,Irino T,Ito H,Inoue Y,Ohashi M,Nunobe S,Takahashi Y. Robotic pancreatectomy as an adjunct to radical gastrectomy for advanced gastric cancer: Surgical and clinical implications. Ann. Surg. Oncol.. 2025; : . DOI: 10.1245/s10434-025-18708-5.
26. Matsui R,Ohashi M,Ri M,Makuuchi R,Hayami M,Irino T,Sano T,Nunobe S. Postoperative impact of anti‐inflammatory drug on cancer recurrence in patients with locally advanced gastric cancer after curative gastrectomy: A pilot retrospective study. Ann. Gastroenterol. Surg.. 2025; (ags3.70110): . DOI: 10.1002/ags3.70110.
27. Morito A,Eto K,Tsubakihara H,Ida S,Makuuchi R,Miyazaki N,Irino T,Hayami M,Nunobe S,Iwatsuki M. Impact of gastrectomy for gastric cancer on postoperative bone mineral density loss and fracture risk: A multicenter study. Clin. Nutr.. 2025; 53: 46029. DOI: 10.1016/j.clnu.2025.08.010.
28. Hu Q,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Oncological impact of unexpected horizontal tumour spread in oesophagogastric junction cancer. BJS Open. 2025; 9(5): 46031. DOI: 10.1093/bjsopen/zraf119.
29. Yamagata Y,Furuta M,Notsu A,Yasui H,Makuuchi R,Yamada T,Ishida M,Tsuji K,Baba S,Tokumoto N,Haruta S,Watanabe M,Hamakawa T,Kawachi Y,Sugisawa N,Yabusaki H,Kawabata R,Kurokawa Y,Boku N,Terashima M,Machida N,Yoshikawa T. Efficacy of nodal dissection for locoregional gastric neuroendocrine carcinoma: a multicenter retrospective observational study. Gastric Cancer. 2025; 28(5): 1004-1016. DOI: 10.1007/s10120-025-01636-4.
30. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Preoperative low prealbumin independently predicts non-gastric cancer death after gastrectomy in elderly and young patients: a retrospective cohort study. Surg. Today. 2025; 55(8): 1068-1078. DOI: 10.1007/s00595-025-02996-1.
31. Hayami M,Ohashi M,Ri M,Makuuchi R,Irino T,Sano T,Nunobe S. Maintenance of resection margins in gastrectomy for cancer: simple in procedure, influential in survival-current status and literature review on optimal lengths and positive margins. Surg. Today. 2025; 55(8): 1013-1023. DOI: 10.1007/s00595-025-03068-0.
32. Matsui R,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Prognostic impact of postoperative fixed-point inflammation in patients with gastric cancer after curative gastrectomy: A validation cohort study. Ann. Gastroenterol. Surg.. 2025; 9(4): 698-710. DOI: 10.1002/ags3.70006.
33. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Elevated prealbumin levels after preoperative nutritional intervention is an independent prognostic factor for overall survival after radical gastrectomy in patients with gastric cancer and severe malnutrition. Langenbecks Arch. Surg.. 2025; 410(1): 206. DOI: 10.1007/s00423-025-03785-7.
34. Matsui R,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Oncological impact of the preoperative combined assessment of skeletal muscle mass for patients undergoing curative gastrectomy for gastric cancer. Surg. Today. 2025; 55(7): 875-885. DOI: 10.1007/s00595-024-02978-9.
35. Matsui R,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Worse oncological impact of preoperative anemia in patients with locally advanced gastric cancer after curative gastrectomy: A retrospective cohort study. Eur. J. Surg. Oncol.. 2025; 51(7): 109762. DOI: 10.1016/j.ejso.2025.109762.
36. Hu Q,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Minimum resection length to ensure a pathologically negative distal margin and a larger remnant stomach for esophagogastric junction cancer. Gastric Cancer. 2025; 28(3): 493-500. DOI: 10.1007/s10120-025-01581-2.
37. Ri M,Hayami M,Ohashi M,Makuuchi R,Irino T,Sano T,Nunobe S. Possibly more favorable short-term outcomes with minimally invasive surgery than with open surgery in total gastrectomy for locally advanced gastric cancer: A single high-volume center study. Ann. Gastroenterol. Surg.. 2025; 9(3): 439-447. DOI: 10.1002/ags3.12881.
38. Terayama M,Kumagai K,Ri M,Makuuchi R,Hayami M,Ida S,Ohashi M,Sano T,Nunobe S. Feasibility of a "stomach-preserving strategy" for perforated gastric cancer in patients with distant metastasis. In Vivo. 2025; 39(2): 969-975. DOI: 10.21873/invivo.13902.
39. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Post-radical gastrectomy long-term survival and etiologies of mortalities in older adult patients greater than 80 years of age with gastric cancer. World J. Surg.. 2025; 49(1): 230-240. DOI: 10.1002/wjs.12405.
40. Irino T,Ohashi M,Hayami M,Makuuchi R,Ri M,Sano T,Yamaguchi T,Nunobe S. Updated review of proximal gastrectomy for gastric cancer or cancer of the gastroesophageal junction. J. Gastric Cancer. 2025; 25(1): 228-246. DOI: 10.5230/jgc.2025.25.e12.
41. Terayama M,Ohashi M,Yamaguchi K,Takahari D,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. Feasibility and predictive factors on the completion of docetaxel plus S-1 adjuvant chemotherapy in pathological stage III gastric cancer. Ann. Gastroenterol. Surg.. 2025; 9(1): 60-68. DOI: 10.1002/ags3.12840.
42. Ri M,Nishie N,Ohashi M,Fukuoka S,Yamaguchi K,Makuuchi R,Hayami M,Irino T,Sano T,Nunobe S. Advantages of adjuvant chemotherapy using S-1 following minimally invasive gastrectomy for gastric cancer versus open surgery: a propensity score-matched analysis. Gastric Cancer. 2025; 28(1): 122-130. DOI: 10.1007/s10120-024-01565-8.
43. Terayama M,Ohashi M,Ri M,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. Possible muscle-sparing advantage and bodyweight maintenance of laparoscopic gastrectomy for older patients with locally advanced gastric cancer. Langenbecks Arch. Surg.. 2024; 409(1): 365. DOI: 10.1007/s00423-024-03554-y.
44. Matsui R,Nunobe S,Ri M,Makuuchi R,Irino T,Hayami M,Ohashi M,Sano T. Prealbumin prognostic score: A novel prognostic indicator after radical gastrectomy in patients with gastric cancer. Cancers (Basel). 2024; 16(22): 3889. DOI: 10.3390/cancers16223889.
45. Hu Q,Ohashi M,Ri M,Makuuchi R,Irino T,Hayami M,Sano T,Nunobe S. Safety of robotic double-flap technique following proximal gastrectomy in the introductory phase compared with laparoscopic procedure: a propensity score-matched analysis. Surg. Endosc.. 2024; 38(10): 5824-5831. DOI: 10.1007/s00464-024-11156-4.
46. Yamaguchi T,Kumagai K,Yagi S,Nomura T,Nagashima K,Watanabe M,Makuuchi R,Kawakami K,Matsushima T,Kadowaki S,Haruta S,Cho H,Kakihara N,Otsuka S,Yamada T,Imai Y,Boku N. Efficacy of chemotherapy for patients with gastric cancer with early recurrence during or after adjuvant chemotherapy with S-1 alone: a multicenter retrospective study. Sci. Rep.. 2024; 14(1): 21854. DOI: 10.1038/s41598-024-72423-x.
47. Kumagai K,Yoshida M,Ishida H,Ishizuka N,Ohashi M,Makuuchi R,Hayami M,Ida S,Yoshimizu S,Horiuchi Y,Ishiyama A,Yoshio T,Hirasawa T,Fujisaki J,Nunobe S. Diagnostic performance of near-infrared fluorescent marking clips in laparoscopic gastrectomy. J. Surg. Res.. 2024; 300: 157-164. DOI: 10.1016/j.jss.2024.05.003.
48. Izumi D,Nunobe S,Ishizuka N,Yagi T,Hayami M,Makuuchi R,Ohashi M,Watanabe M,Sano T. Identification of the factor affecting learning curves of laparoscopic gastrectomy through the experience at a Japanese high-volume center over the last decade. Ann. Gastroenterol. Surg.. 2024; 8(4): 604-610. DOI: 10.1002/ags3.12782.
49. Harada H,Eto K,Ohashi M,Kurihara N,Ri M,Makuuchi R,Ida S,Hayami M,Kumagai K,Sano T,Nunobe S. Equal short-term outcomes of intracorporeal mechanical gastrogastrostomy in laparoscopic pylorus-preserving gastrectomy for cT1N0 gastric cancer in the middle stomach compared with the extracorporeal hand-sewing method. Surg. Endosc.. 2024; 38(6): 3115-3125. DOI: 10.1007/s00464-024-10823-w.
50. Matsui R,Ida S,Ri M,Makuuchi R,Hayami M,Kumagai K,Ohashi M,Sano T,Nunobe S. Impact of preoperative prealbumin levels on long-term prognosis in patients with gastric cancer after gastrectomy: a retrospective cohort study. Gastric Cancer. 2024; 27(3): 611-621. DOI: 10.1007/s10120-024-01472-y.
51. Ri M,Ohashi M,Makuuchi R,Hayami M,Sano T,Nunobe S. Clinical impact of polyglycolic acid mesh to reduce pancreas-related complications after minimally invasive surgery for gastric cancer: A propensity score matching analysis. J. Gastric Cancer. 2024; 24(2): 220-230. DOI: 10.5230/jgc.2024.24.e17.
52. Terayama M,Ohashi M,Ri M,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. Long-term impact of sarcopenia in older patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis. Transl. Gastroenterol. Hepatol.. 2023; 8: 35. DOI: 10.21037/tgh-23-34.
53. Oba A,Maekawa A,Inoue Y,Makuuchi R,Omiya K,Kobayashi K,Ono Y,Sato T,Ohashi M,Ito H,Nunobe S,Takahashi Y. Robotic splenic vessels preserving distal pancreatectomy in a post-distal gastrectomy patient. Ann. Surg. Oncol.. 2023; 30(11): 6680-6681. DOI: 10.1245/s10434-023-13802-y.
54. Oba A,Maekawa A,Makuuchi R,Inoue Y,Takahashi Y. ASO author reflections: Open/robotic-splenic vessels preserving distal pancreatectomy can be a good option for post-distal gastrectomy patients. Ann. Surg. Oncol.. 2023; 30(11): 6682-6683. DOI: 10.1245/s10434-023-13837-1.
55. Matsui R,Nunobe S,Makuuchi R,Hayami M,Ida S,Kumagai K,Ohashi M,Sano T. Relationship between antithrombotic drugs and postoperative outcomes in patients with gastric cancer after gastrectomy: a propensity matching analysis. Gastric Cancer. 2023; 26(5): 833-842. DOI: 10.1007/s10120-023-01410-4.
56. Koterazawa Y,Ohashi M,Hayami M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Oncological impact of unexpected horizontal tumor spread in gastric cancer that requires total gastrectomy. Gastric Cancer. 2023; 26(5): 823-832. DOI: 10.1007/s10120-023-01401-5.
57. Kumagai K,Nunobe S,Hiki N,Hayami M,Ishizuka N,Ida S,Makuuchi R,Jiang X,Ohashi M,Sano T. Anatomical position of the pancreas as a risk factor for pancreatic fistula after laparoscopic gastrectomy for gastric cancer. World J. Surg.. 2023; 47(7): 1744-1751. DOI: 10.1007/s00268-023-06972-z.
58. Kumagai K,Nunobe S,Hiki N,Hayami M,Ishizuka N,Ida S,Makuuchi R,Jiang X,Ohashi M,Sano T. Anatomical position of the pancreas as a risk factor for pancreatic fistula after laparoscopic gastrectomy for gastric cancer. World J. Surg.. 2023; 47(7): 1744-1751. DOI: 10.1007/s00268-023-06972-z.
59. Terayama M,Kumagai K,Kawachi H,Makuuchi R,Hayami M,Ida S,Ohashi M,Sano T,Nunobe S. Optimal resection of gastric bronchogenic cysts based on anatomical continuity with adherent gastric muscular layer: A case report. World J. Gastrointest. Surg.. 2023; 15(6): 1216-1223. DOI: 10.4240/wjgs.v15.i6.1216.
60. Koterazawa Y,Ohashi M,Hayami M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Required esophageal resection length beyond the tumor boundary to ensure a negative proximal margin for gastric cancer with gross esophageal invasion or esophagogastric junction cancer. Gastric Cancer. 2023; 26(3): 451-459. DOI: 10.1007/s10120-023-01369-2.
61. Harada H,Hayami M,Makuuchi R,Ida S,Kumagai K,Ohashi M,Nunobe S. A sandwiching method that simplifies hepatic left lateral segment inversion to secure an optimal surgical view around the esophageal hiatus in laparoscopic and robotic gastrectomy for upper gastric and esophagogastric junction cancers. Langenbecks Arch. Surg.. 2023; 408(1): 159. DOI: 10.1007/s00423-023-02901-9.
62. Otake R,Kumagai K,Ohashi M,Makuuchi R,Ida S,Sano T,Nunobe S. ASO author reflections: Severe reflux esophagitis after laparoscopic pylorus-preserving gastrectomy for gastric cancer is associated with male sex, preoperative grade A reflux esophagitis, postoperative BMI of ≥23 kg/m2, hiatal hernia, and long-term gastric stasis. Ann. Surg. Oncol.. 2023; 30(4): 2304-2305. DOI: 10.1245/s10434-022-12949-4.
63. Otake R,Kumagai K,Ohashi M,Makuuchi R,Ida S,Sano T,Nunobe S. Reflux esophagitis after laparoscopic pylorus-preserving gastrectomy for gastric cancer. Ann. Surg. Oncol.. 2023; 30(4): 2294-2303. DOI: 10.1245/s10434-022-12902-5.
64. Terayama M,Ohashi M,Ida S,Hayami M,Makuuchi R,Kumagai K,Sano T,Nunobe S. Advantages of function-preserving gastrectomy for older patients with upper-third early gastric cancer: Maintenance of nutritional status and favorable survival. J. Gastric Cancer. 2023; 23(2): 303-314. DOI: 10.5230/jgc.2023.23.e9.
65. Yagi S,Ida S,Namikawa K,Hayami M,Makuuchi R,Kumagai K,Ohashi M,Sano T,Nunobe S. Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer. Surg. Today. 2023; 53(3): 360-368. DOI: 10.1007/s00595-022-02567-8.
66. Yagi S,Ida S,Namikawa K,Hayami M,Makuuchi R,Kumagai K,Ohashi M,Sano T,Nunobe S. Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer. Surg. Today. 2023; 53(3): 360-368. DOI: 10.1007/s00595-022-02567-8.
67. Terayama M,Ohashi M,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. A continuous muscle-sparing advantage of pylorus-preserving gastrectomy for older patients with cT1N0M0 gastric cancer in the middle third of the stomach. Gastric Cancer. 2023; 26(1): 145-154. DOI: 10.1007/s10120-022-01345-2.
68. Inoue Y,Sato T,Kato T,Oba A,Ono Y,Ito H,Makuuchi R,Takahashi Y. How can we optimize surgical view during robotic-assisted pancreaticoduodenectomy? Feasibility of multiple scope transition method. J. Am. Coll. Surg.. 2022; 235(4): e1-e7. DOI: 10.1097/XCS.0000000000000281.
69. Koterazawa Y,Ohashi M,Hayami M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Minimum resection length to ensure a pathologically negative distal margin and the preservation of a larger remnant stomach in proximal gastrectomy for early upper gastric cancer. Gastric Cancer. 2022; 25(5): 973-981. DOI: 10.1007/s10120-022-01304-x.
70. Harada H,Ohashi M,Hiki N,Fujisaki J,Hirasawa T,Yamamoto Y,Makuuchi R,Ida S,Hayami M,Kumagai K,Sano T,Nunobe S. Excellent oncological outcomes besides short-term safety of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor. Endosc. Int. Open. 2022; 10(9): E1254-E1260. DOI: 10.1055/a-1895-9507.
71. Yasufuku I,Ohashi M,Makuuchi R,Hayami M,Ida S,Kumagai K,Sano T,Nunobe S. High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy. Eur. J. Surg. Oncol.. 2022; 48(8): 1746-1752. DOI: 10.1016/j.ejso.2022.01.011.
72. Nishie N,Ohashi M,Makuuchi R,Hayami M,Ida S,Kumagai K,Nunobe S,Sano T. Successful open radical gastrectomy for locally advanced or metastatic gastric cancer patients who suffered from coronavirus disease 2019 during preoperative chemotherapy: a report of three cases. Surg. Case Rep.. 2022; 8(1): 124. DOI: 10.1186/s40792-022-01465-y.
73. Izumi D,Ida S,Hayami M,Makuuchi R,Kumagai K,Ohashi M,Watanabe M,Sano T,Nunobe S. Increased rate of serum prealbumin level after preoperative enteral nutrition as an indicator of morbidity in gastrectomy for gastric cancer with outlet obstruction. World J. Surg.. 2022; 46(3): 624-630. DOI: 10.1007/s00268-021-06384-x.
74. Muneoka Y,Ohashi M,Ishizuka N,Hayami M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection?. Gastric Cancer. 2022; 25(1): 287-296. DOI: 10.1007/s10120-021-01238-w.
75. Shoji Y,Nunobe S,Nishie N,Yagi S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Ishiyama A,Yoshio T,Hirasawa T,Fujisaki J,Sano T. Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy. Endosc. Int. Open. 2022; 10(1): E62-E73. DOI: 10.1055/a-1635-5855.
76. Ri M,Nunobe S,Ida S,Ishizuka N,Atsumi S,Hayami M,Makuuchi R,Kumagai K,Ohashi M,Sano T. Postprandial asymptomatic glycemic fluctuations after gastrectomy for gastric cancer using continuous glucose monitoring device. J. Gastric Cancer. 2021; 21(4): 325-334. DOI: 10.5230/jgc.2021.21.e31.
77. Kano Y,Ohashi M,Muneoka Y,Takahari D,Chin K,Yamaguchi K,Ida S,Kumagai K,Makuuchi R,Sano T,Nunobe S. Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy. Eur. J. Surg. Oncol.. 2021; 47(12): 3097-3104. DOI: 10.1016/j.ejso.2021.04.018.
78. Ri M,Kumagai K,Namikawa K,Atsumi S,Hayami M,Makuuchi R,Ida S,Ohashi M,Sano T,Nunobe S. Is proximal gastrectomy indicated for locally advanced cancer in the upper third of the stomach?. Ann. Gastroenterol. Surg.. 2021; 5(6): 767-775. DOI: 10.1002/ags3.12486.
79. Ri M,Ohashi M,Eto K,Ishizuka N,Atsumi S,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Favorable outcomes of neoadjuvant chemotherapy and limited para-aortic lymph node dissection for advanced gastric cancer with para-aortic lymph node metastasis. World J. Surg.. 2021; 45(9): 2849-2859. DOI: 10.1007/s00268-021-06184-3.
80. Muneoka Y,Ohashi M,Kurihara N,Fujisaki J,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Short- and long-term oncological outcomes of totally laparoscopic gastrectomy versus laparoscopy-assisted gastrectomy for clinical stage I gastric cancer. Gastric Cancer. 2021; 24(5): 1140-1149. DOI: 10.1007/s10120-021-01181-w.
81. Muneoka Y,Ohashi M,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Advantageous short-term outcomes of esophagojejunostomy using a linear stapler following open total gastrectomy compared with a circular stapler. World J. Surg.. 2021; 45(8): 2501-2509. DOI: 10.1007/s00268-021-06100-9.
82. Ri M,Nunobe S,Ida S,Ishizuka N,Atsumi S,Makuuchi R,Kumagai K,Ohashi M,Sano T. Preliminary prospective study of real-time post-gastrectomy glycemic fluctuations during dumping symptoms using continuous glucose monitoring. World J. Gastroenterol.. 2021; 27(23): 3386-3395. DOI: 10.3748/wjg.v27.i23.3386.
83. Ri M,Nunobe S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Key factors for maintaining postoperative skeletal muscle mass after laparoscopic proximal gastrectomy with double-flap technique reconstruction for early gastric cancer. J. Gastrointest. Surg.. 2021; 25(6): 1569-1572. DOI: 10.1007/s11605-020-04846-6.
84. Ri M,Nunobe S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Is laparoscopic and endoscopic cooperative surgery (LECS) for gastric subepithelial tumor at the esophagogastric junction safe?. Asian J. Endosc. Surg.. 2021; 14(2): 223-231. DOI: 10.1111/ases.12857.
85. Kumagai K,Hiki N,Nunobe S,Jiang X,Makuuchi R,Ida S,Ohashi M,Yamaguchi T,Sano T. Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high-volume center. Surg. Endosc.. 2021; 35(4): 1834-1842. DOI: 10.1007/s00464-020-07584-7.
86. Kumagai K,Hiki N,Nunobe S,Jiang X,Makuuchi R,Ida S,Ohashi M,Yamaguchi T,Sano T. Correction to: Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high‑volume center. Surg. Endosc.. 2021; 35(4): 1843. DOI: 10.1007/s00464-020-07774-3.
87. Takahashi R,Nunobe S,Sai N,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Pancreatic atrophy after gastrectomy for gastric cancer. Surg. Today. 2021; 51(3): 432-438. DOI: 10.1007/s00595-020-02131-2.
88. Yagi S,Nunobe S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Oncological outcomes in patients with pT1N0-3 or pT2-3N0 gastric cancer after curative resection without adjuvant chemotherapy. Langenbecks Arch. Surg.. 2021; 406(2): 419-426. DOI: 10.1007/s00423-021-02084-1.
89. Honda S,Furukawa K,Makuuchi R,Irino T,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Shinsato K,Matsumoto T,Terashima M. A phase II study of ramelteon for the prevention of postoperative delirium in elderly patients undergoing gastrectomy. Surg. Today. 2020; 50(12): 1681-1686. DOI: 10.1007/s00595-020-02073-9.
90. Kaji S,Irino T,Kusuhara M,Makuuchi R,Yamakawa Y,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Kami K,Ohashi Y,Zhang S,Orita H,Lee-Okada HC,Fukunaga T,Terashima M. Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence. Gastric Cancer. 2020; 23(5): 874-883. DOI: 10.1007/s10120-020-01065-5.
91. Kano Y,Ohashi M,Ida S,Kumagai K,Makuuchi R,Sano T,Hiki N,Nunobe S. Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types. Gastric Cancer. 2020; 23(5): 927-936. DOI: 10.1007/s10120-020-01072-6.
92. Takahashi R,Ohashi M,Hiki N,Makuuchi R,Ida S,Kumagai K,Sano T,Nunobe S. Risk factors and prognosis of gastric stasis, a crucial problem after laparoscopic pylorus-preserving gastrectomy for early middle-third gastric cancer. Gastric Cancer. 2020; 23(4): 707-715. DOI: 10.1007/s10120-019-01037-4.
93. Takahashi R,Nunobe S,Makuuchi R,Ida S,Kumagai K,Ohashi M,Sano T. Survival outcomes of elderly patients with pathological stages II and III gastric cancer following curative gastrectomy. Ann. Gastroenterol. Surg.. 2020; 4(4): 433-440. DOI: 10.1002/ags3.12339.
94. Yamaguchi T,Takashima A,Nagashima K,Makuuchi R,Aizawa M,Ohashi M,Tashiro K,Yamada T,Kinoshita T,Hata H,Kawachi Y,Kawabata R,Tsuji T,Hihara J,Sakamoto T,Fukagawa T,Katai H,Higuchi K,Boku N. Efficacy of postoperative chemotherapy after resection that leaves no macroscopically visible disease of Gastric Cancer with positive peritoneal lavage cytology (CY1) or localized peritoneum metastasis (P1a): A multicenter retrospective study. Ann. Surg. Oncol.. 2020; 27(1): 284-292. DOI: 10.1245/s10434-019-07697-x.
95. Waki Y,Irino T,Makuuchi R,Notsu A,Kamiya S,Tanizawa Y,Bando E,Kawamura T,Terashima M. Impact of preoperative skeletal muscle quality measurement on long-term survival after curative gastrectomy for locally advanced gastric cancer. World J. Surg.. 2019; 43(12): 3083-3093. DOI: 10.1007/s00268-019-05145-1.
96. Fujiya K,Irino T,Furukawa K,Omori H,Makuuchi R,Tanizawa Y,Bando E,Terashima M. Safety of prolonged wait time for gastrectomy in clinical stage I gastric cancer. Eur. J. Surg. Oncol.. 2019; 45(10): 1964-1968. DOI: 10.1016/j.ejso.2019.06.006.
97. Matsubayashi H,Matsui T,Sugiura T,Makuuchi R,Kaneko J,Satoh J,Satoh T,Fujie S,Ishiwatari H,Sasaki K,Ono H. A large carcinosarcoma of the gallbladder accompanied by pancreaticobiliary maljunction: A case with a six-year survival. Intern. Med.. 2019; 58(19): 2809-2817. DOI: 10.2169/internalmedicine.2783-19.
98. Furukawa K,Irino T,Makuuchi R,Koseki Y,Nakamura K,Waki Y,Fujiya K,Omori H,Tanizawa Y,Bando E,Kawamura T,Terashima M. Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer. Gastric Cancer. 2019; 22(4): 864-872. DOI: 10.1007/s10120-018-00910-y.
99. Asaoka R,Kawamura T,Makuuchi R,Irino T,Tanizawa Y,Bando E,Terashima M. Risk factors for 30-day hospital readmission after radical gastrectomy: a single-center retrospective study. Gastric Cancer. 2019; 22(2): 413-420. DOI: 10.1007/s10120-018-0856-4.
100. Omori H,Tanizawa Y,Makuuchi R,Irino T,Bando E,Kawamura T,Terashima M. Role of palliative resection in patients with incurable advanced gastric cancer who are unfit for chemotherapy. World J. Surg.. 2019; 43(2): 571-579. DOI: 10.1007/s00268-018-4816-2.
101. Asaoka R,Irino T,Makuuchi R,Tanizawa Y,Bando E,Kawamura T,Terashima M. Changes in body weight, skeletal muscle and adipose tissue after gastrectomy: a comparison between proximal gastrectomy and total gastrectomy. ANZ J. Surg.. 2019; 89(46024): 79-83. DOI: 10.1111/ans.15023.
102. Honda S,Furukawa K,Nishiwaki N,Fujiya K,Omori H,Kaji S,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Risk factors for postoperative delirium after gastrectomy in gastric cancer patients. World J. Surg.. 2018; 42(11): 3669-3675. DOI: 10.1007/s00268-018-4682-y.
103. Fujiya K,Tokunaga M,Nishiwaki N,Furukawa K,Omori H,Kaji S,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Feasibility of laparoscopic distal gastrectomy for stage I gastric cancer in patients outside of clinical trials. J. Gastrointest. Surg.. 2018; 22(10): 1665-1671. DOI: 10.1007/s11605-018-3842-6.
104. Hikage M,Tokunaga M,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Reply to comment on "Are body mass index and performance status enough to assess the nutritional and functional status of elderly patients undergoing gastric cancer surgery?". Surg. Today. 2018; 48(12): 1102-1103. DOI: 10.1007/s00595-018-1702-3.
105. Hikage M,Tokunaga M,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Surgical outcomes after gastrectomy in very elderly patients with gastric cancer. Surg. Today. 2018; 48(8): 773-782. DOI: 10.1007/s00595-018-1651-x.
106. Hikage M,Tokunaga M,Makuuchi R,Irino T,Tanizawa Y,Bando E,Kawamura T,Terashima M. Comparison of surgical outcomes between robotic and laparoscopic distal gastrectomy for cT1 gastric cancer. World J. Surg.. 2018; 42(6): 1803-1810. DOI: 10.1007/s00268-017-4345-4.
107. Fujiya K,Kawamura T,Omae K,Makuuchi R,Irino T,Tokunaga M,Tanizawa Y,Bando E,Terashima M. Impact of malnutrition after gastrectomy for gastric cancer on long-term survival. Ann. Surg. Oncol.. 2018; 25(4): 974-983. DOI: 10.1245/s10434-018-6342-8.
108. Fujiya K,Takizawa K,Tokunaga M,Kawata N,Hikage M,Makuuchi R,Tanizawa Y,Bando E,Kawamura T,Tanaka M,Kakushima N,Ono H,Terashima M. The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer. Gastric Cancer. 2018; 21(1): 124-132. DOI: 10.1007/s10120-017-0724-7.
109. Furukawa K,Tanizawa Y,Kusafuka K,Nishiwaki N,Fujiya K,Omori H,Kaji S,Hikage M,Makuuchi R,Irino T,Tokunaga M,Bando E,Kawamura T,Terashima M. Amputation neuroma mimicking lymph node metastasis of remnant gastric cancer: a case report. Surg. Case Rep.. 2017; 3(1): 123. DOI: 10.1186/s40792-017-0396-x.
110. Tanizawa Y,Bando E,Kawamura T,Tokunaga M,Makuuchi R,Iida K,Nanri K,Yoneyama M,Terashima M. Prevalence of deep venous thrombosis detected by ultrasonography before surgery in patients with gastric cancer: a retrospective study of 1140 consecutive patients. Gastric Cancer. 2017; 20(5): 878-886. DOI: 10.1007/s10120-016-0677-2.
111. Honda S,Bando E,Makuuchi R,Tokunaga M,Tanizawa Y,Kawamura T,Sugiura T,Kinugasa Y,Uesaka K,Terashima M. Effects of initial disease status on lymph flow following gastrectomy in cases of carcinoma in the remnant stomach. Gastric Cancer. 2017; 20(3): 457-464. DOI: 10.1007/s10120-016-0640-2.
112. Kawata N,Kakushima N,Takizawa K,Tanaka M,Makuuchi R,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Sugino T,Kusafuka K,Shimoda T,Nakajima T,Terashima M,Ono H. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection. Surg. Endosc.. 2017; 31(4): 1607-1616. DOI: 10.1007/s00464-016-5148-7.
113. Fujiya K,Tokunaga M,Makuuchi R,Nishiwaki N,Omori H,Takagi W,Hirata F,Hikage M,Tanizawa Y,Bando E,Kawamura T,Terashima M. Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer. Gastric Cancer. 2017; 20(Suppl 1): 141-149. DOI: 10.1007/s10120-016-0661-x.
114. Yamashita H,Seto Y,Sano T,Makuuchi H,Ando N,Sasako M,Japanese Gastric Cancer Association and the Japan Esophageal Society. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017; 20(Suppl 1): 69-83. DOI: 10.1007/s10120-016-0663-8.
115. Hikage M,Tokunaga M,Makuuchi R,Tanizawa Y,Bando E,Kawamura T,Terashima M. Impact of an ultrasonically activated device in robot-assisted distal gastrectomy. Innovations (Phila.). 2017; 12(6): 453-458. DOI: 10.1097/IMI.0000000000000437.
116. Fujiya K,Tokunaga M,Mori K,Makuuchi R,Tanizawa Y,Bando E,Kawamura T,Terashima M. Long-term survival in patients with postoperative intra-abdominal infectious complications after curative gastrectomy for gastric cancer: A propensity score matching analysis. Ann. Surg. Oncol.. 2016; 23(Suppl 5): 809-816. DOI: 10.1245/s10434-016-5577-5.
117. Yoshida M,Sugino T,Kusafuka K,Nakajima T,Makuuchi R,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Terashima M,Kawata N,Tanaka M,Kakushima N,Takizawa K,Ono H. Peritoneal dissemination in early gastric cancer: importance of the lymphatic route. Virchows Arch.. 2016; 469(2): 155-161. DOI: 10.1007/s00428-016-1960-7.
118. Sugisawa N,Tokunaga M,Makuuchi R,Miki Y,Tanizawa Y,Bando E,Kawamura T,Terashima M. A phase II study of an enhanced recovery after surgery protocol in gastric cancer surgery. Gastric Cancer. 2016; 19(3): 961-967. DOI: 10.1007/s10120-015-0528-6.
119. Terashima M,Tokunaga M,Tanizawa Y,Bando E,Kawamura T,Miki Y,Makuuchi R,Honda S,Tatsubayashi T,Takagi W,Omori H,Hirata F. Robotic surgery for gastric cancer. Gastric Cancer. 2015; 18(3): 449-457. DOI: 10.1007/s10120-015-0501-4.
120. Miki Y,Kawamura T,Sugisawa N,Makuuchi R,Nakajima T,Tokunaga M,Tanizawa Y,Bando E,Terashima M. Risk classification using the Ki-67 labeling index for surgically-treated gastric gastrointestinal stromal tumors. Hepatogastroenterology. 2015; 62(140): 919-923.
121. Goto H,Tokunaga M,Miki Y,Makuuchi R,Sugisawa N,Tanizawa Y,Bando E,Kawamura T,Niihara M,Tsubosa Y,Terashima M. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric Cancer. 2014; 18(2): 375-381. DOI: 10.1007/s10120-014-0364-0.
122. Mine S,Udagawa H,Kinoshita Y,Makuuchi R. Post-esophagectomy chylous leakage from a duplicated left-sided thoracic duct ligated successfully with left-sided video-assisted thoracoscopic surgery. Interact. Cardiovasc. Thorac. Surg.. 2008; 7(6): 1186-1188. DOI: 10.1510/icvts.2008.185306.

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

幕内 梨恵（マクウチ リエ）

幕内梨恵（マクウチリエ）